nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.0567	0.0567	CcSEcCtD
Sitagliptin—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.047	0.047	CcSEcCtD
Sitagliptin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0335	0.0335	CcSEcCtD
Sitagliptin—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0295	0.0295	CcSEcCtD
Sitagliptin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0261	CcSEcCtD
Sitagliptin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.024	0.024	CcSEcCtD
Sitagliptin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0191	CcSEcCtD
Sitagliptin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0172	CcSEcCtD
Sitagliptin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0169	CcSEcCtD
Sitagliptin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0166	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0157	CcSEcCtD
Sitagliptin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0155	CcSEcCtD
Sitagliptin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Sitagliptin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0146	0.0146	CcSEcCtD
Sitagliptin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0143	CcSEcCtD
Sitagliptin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0143	CcSEcCtD
Sitagliptin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Sitagliptin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0135	CcSEcCtD
Sitagliptin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Sitagliptin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Sitagliptin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Sitagliptin—Depression—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Sitagliptin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0129	0.0129	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0125	CcSEcCtD
Sitagliptin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Sitagliptin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Sitagliptin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Sitagliptin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0118	CcSEcCtD
Sitagliptin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Sitagliptin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Sitagliptin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Sitagliptin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Sitagliptin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Sitagliptin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Sitagliptin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Sitagliptin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Sitagliptin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Sitagliptin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Sitagliptin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0104	CcSEcCtD
Sitagliptin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Sitagliptin—Tension—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0102	CcSEcCtD
Sitagliptin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Sitagliptin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.01	0.01	CcSEcCtD
Sitagliptin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00996	0.00996	CcSEcCtD
Sitagliptin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00961	0.00961	CcSEcCtD
Sitagliptin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00947	0.00947	CcSEcCtD
Sitagliptin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00934	0.00934	CcSEcCtD
Sitagliptin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00931	0.00931	CcSEcCtD
Sitagliptin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00904	0.00904	CcSEcCtD
Sitagliptin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00894	0.00894	CcSEcCtD
Sitagliptin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00882	0.00882	CcSEcCtD
Sitagliptin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00882	0.00882	CcSEcCtD
Sitagliptin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00879	0.00879	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00876	0.00876	CcSEcCtD
Sitagliptin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00871	0.00871	CcSEcCtD
Sitagliptin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00863	0.00863	CcSEcCtD
Sitagliptin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00845	0.00845	CcSEcCtD
Sitagliptin—Infection—Riluzole—amyotrophic lateral sclerosis	0.0084	0.0084	CcSEcCtD
Sitagliptin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00829	0.00829	CcSEcCtD
Sitagliptin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00821	0.00821	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0077	0.0077	CcSEcCtD
Sitagliptin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00765	0.00765	CcSEcCtD
Sitagliptin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00752	0.00752	CcSEcCtD
Sitagliptin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00744	0.00744	CcSEcCtD
Sitagliptin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00735	0.00735	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0073	CcSEcCtD
Sitagliptin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00729	0.00729	CcSEcCtD
Sitagliptin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00723	CcSEcCtD
Sitagliptin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00723	CcSEcCtD
Sitagliptin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00697	0.00697	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00691	0.00691	CcSEcCtD
Sitagliptin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00672	CcSEcCtD
Sitagliptin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00668	0.00668	CcSEcCtD
Sitagliptin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00623	0.00623	CcSEcCtD
Sitagliptin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00607	CcSEcCtD
Sitagliptin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00578	0.00578	CcSEcCtD
Sitagliptin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00559	0.00559	CcSEcCtD
Sitagliptin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00538	0.00538	CcSEcCtD
Sitagliptin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00533	CcSEcCtD
Sitagliptin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00533	CcSEcCtD
Sitagliptin—Headache—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0053	CcSEcCtD
Sitagliptin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00502	CcSEcCtD
